Injecting more frequently does not improve results and increases side effects and medication waste
Cost ranges reflect approximate US cash prices without insurance as of early 2026
Case 2 does not follow any of the two endotypes but responded to the treatment in the same time frame
GLP-1/GIP, GLP-1/glucagon, and even triple agonists are the dominant focus, though the spectrum extends to other mechanisms as wellamylin, GIP antagonism, NK2 receptor agonism, and more, said DiMarchi Looking further ahead, DiMarchi sees potential for oral therapies, including oral peptides
Kokate ,A.P
Considering the potential appetite-reducing effects of GLP-1 RAs, diet-restricted control groups were included for both drugs, ensuring consistent food intake between treatment and control groups, thereby minimizing any dietary bias